STRATEGY STUDIO / PUBLIC DATA EXPLORER

ACCESS TO ADVANCED HEALTH INSTITUTE: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
ACCESS TO ADVANCED HEALTH INSTITUTE (EIN 91-1608978)
Tax period
2015-01-01 to 2015-12-31
Filed
2016-11-14
IRS object ID
201623199349303287
Schema version
2015v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2016-11-14T10:49:28-06:00ReturnTs
Tax Period End2015-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN911194016PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLARK NUBER PSBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line110900 NE 4TH STREET SUITE 1700AddressLine1Txt
CityBELLEVUECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98004ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2015-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN911608978EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1INFECTIOUS DISEASE RESEARCH INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlINFEBusinessNameControlTxt
Phone2063810883PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11616 EASTLAKE AVE E NO 400AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98102ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonC STEPHEN CORDIALPersonNm
Person TitleCFOPersonTitleTxt
Phone2063810883PhoneNum
Signature2016-11-09SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJANE M SEARINGPreparerPersonNm
PTINP00000565PTIN
Phone4254544919PhoneNum
Preparation2016-11-09PreparationDt
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2017-02-10 21:41:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerC STEPHEN CORDIALPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11616 EASTLAKE AVE E NO 400AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98102ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$30,092,807GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.IDRI.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1993FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionDEVELOP VACCINES, DIAGNOSTICS & DRUGS TO PREVENT, DETECT & TREAT INFECTIOUS DISEASES OF POVERTY.ActivityOrMissionDesc
Voting Members Governing Body10VotingMembersGoverningBodyCnt
Voting Members Independent8VotingMembersIndependentCnt
Total Employee163TotalEmployeeCnt
Total Volunteers8TotalVolunteersCnt
Total Gross UBI$429,875TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm-$383,844NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$9,413,720PYContributionsGrantsAmt
CY Contributions Grants$19,664,811CYContributionsGrantsAmt
PY Program Service Revenue$4,038,190PYProgramServiceRevenueAmt
CY Program Service Revenue$6,098,639CYProgramServiceRevenueAmt
PY Investment Income-$6,326PYInvestmentIncomeAmt
CY Investment Income$857,163CYInvestmentIncomeAmt
PY Other Revenue$719,744PYOtherRevenueAmt
CY Other Revenue$1,678,789CYOtherRevenueAmt
PY Total Revenue$14,165,328PYTotalRevenueAmt
CY Total Revenue$28,299,402CYTotalRevenueAmt
PY Grants And Similar Paid$9,000PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$14,000CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$10,726,682PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$10,818,103CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$958PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$205,491CYTotalFundraisingExpenseAmt
PY Other Expenses$13,598,667PYOtherExpensesAmt
CY Other Expenses$14,273,737CYOtherExpensesAmt
PY Total Expenses$24,335,307PYTotalExpensesAmt
CY Total Expenses$25,105,840CYTotalExpensesAmt
PY Revenues Less Expenses-$10,169,979PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$3,193,562CYRevenuesLessExpensesAmt
Total Assets BOY$36,163,621TotalAssetsBOYAmt
Total Assets EOY$37,205,100TotalAssetsEOYAmt
Total Liabilities BOY$19,849,406TotalLiabilitiesBOYAmt
Total Liabilities EOY$21,319,603TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$16,314,215NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$15,885,497NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionAS A "NONPROFIT BIOTECH," IDRI COMBINES THE HIGH-QUALITY SCIENCE OF A RESEARCH ORGANIZATION WITH THE PRODUCT DEVELOPMENT CAPABILITIES OF A BIOTECH COMPANY TO CREATE NEW DIAGNOSTICS, DRUGS AND VACCINES FOR INFECTIOUS DISEASES AND IMPROVE THE HEALTH OF THE WORLD.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$7,528,217ExpenseAmt
Revenue$1,632,502RevenueAmt
DescVACCINE RESEARCH - ONE OF THE GREATEST TRIUMPHS OF PUBLIC HEALTH, VACCINES HAVE BEEN USED FOR DECADES TO BOOST IMMUNITY AND PROTECT AGAINST SERIOUS DISEASES. IDRI SCIENTISTS ARE DEVELOPING INNOVATIVE VACCINES AGAINST DEADLY INFECTIOUS DISEASES SUCH AS TUBERCULOSIS, LEISHMANIASIS, AND LEPROSY, AS WELL AS NEWLY EMERGING THREATS INCLUDING ZIKA AND CHIKUNGUNYA. THE GOAL OF IDRI'S VACCINE WORK IS TO PRODUCE SAFE, EFFECTIVE AND LOW-COST VACCINES AND TO TRANSFER VACCINE TECHNOLOGY AND EXPERTISE TO DEVELOPING COUNTRIES SO THAT VACCINES CAN BE DEVELOPED QUICKLY WHEN DISEASE OUTBREAKS OCCUR. IDRI'S LEADING TUBERCULOSIS VACCINE CANDIDATE (ID93 + GLA-SE) HAS MOVED SUCCESSFULLY THROUGH EARLY STAGE CLINICAL TRIALS IN THE U.S. AND SOUTH AFRICA AND IN IS NOW IN A PHASE 2A CLINICAL TRIAL IN SOUTH AFRICA TO ASSESS THE ABILITY TO REDUCE TB RECURRENCE AFTER TREATMENT.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$3,478,259ExpenseAmt
Revenue$754,264RevenueAmt
DescADJUVANT RESEARCH - ADJUVANTS ARE SUBSTANCES ADDED TO VACCINES THAT ENHANCE THE ABILITY OF ANTIGENS TO STIMULATE THE BODY'S IMMUNE RESPONSE. THEY PROVIDE A KEY BENEFIT TO VACCINE DEVELOPMENT BY: IMPROVING IMMUNE RESPONSE, BROADENING VACCINE PROTECTION AND REDUCING THE AMOUNT OF VACCINE NEEDED.IDRI IS A WORLD LEADER IN ADJUVANT DEVELOPMENT AND HAS DEVELOPED MULTIPLE ADJUVANT FORMULATIONS. IN ADDITION TO VACCINES THAT IDRI IS DEVELOPING FOR TUBERCULOSIS, LEPROSY AND LEISHMANIASIS, IDRI SCIENTISTS ARE ALSO WORKING WITH COLLABORATORS TO PROVIDE ADJUVANTS FOR VACCINES BEING DEVELOPED IN VARIOUS DISEASE AREAS, INCLUDING MALARIA, HIV/AIDS, ZIKA AND PANDEMIC FLU. IN ADDITION, IDRI HAS TRANSFERRED ITS ADJUVANT TECHNOLOGIES TO ROMANIA, BRAZIL, SOUTH AFRICA AND INDIA, WHERE IDRI SCIENTISTS TEACH SCIENTISTS AND ENGINEERS HOW TO MANUFACTURE ADJUVANTS FOR THEIR OWN VACCINES.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$3,847,855ExpenseAmt
Revenue$834,412RevenueAmt
DescTUBERCULOSIS DRUG DISCOVERY - IDRI'S TUBERCULOSIS DRUG DISCOVERY GROUP IS FOCUSED ON DISCOVERING AND DEVELOPING NOVEL DRUGS THAT ARE EFFECTIVE AT CURING DRUG SENSITIVE AND DRUG RESISTANT TB WITH THE ADDED GOAL OF SHORTENING THE TIME IT TAKES TO CURE DISEASE. TO DATE, SCIENTISTS AT IDRI HAVE SCREENED MORE THAN HALF A MILLION COMPOUNDS, CONTINUING THE IDENTIFICATION OF NEW LEADS AND DRUG TARGETS TO COMBAT TB.IDRI IS A FOUNDING MEMBER OF THE LILLY TB DRUG DISCOVERY INITIATIVE - HEADQUARTERED AT IDRI - AND THE TB DRUG ACCELERATOR (TBDA). THE LILLY INITIATIVE IS A UNIQUE PUBLIC-PRIVATE PARTNERSHIP WITH ELI LILLY AND COMPANY AND THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), PART OF THE NATIONAL INSTITUTES OF HEALTH (NIH), WITH A FOCUS ON THE DISCOVERY OF NEW ANTI-TUBERCULOSIS DRUGS. THE TBDA WAS FOUNDED AS A PARTNERSHIP OF SEVEN PHARMACEUTICAL COMPANIES AND FIVE OTHER ORGANIZATIONS, FUNDED IN PART BY THE BILL & MELINDA GATES FOUNDATION, TO TARGET THE DISCOVERY OF NEW TB DRUGS BY COLLABORATING ON EARLY-STAGE DRUG DISCOVERY FOR TUBERCULOSIS.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)

ExpenseExpenseAmtRevenueRevenueAmtDescDescGrantGrantAmt
$796,915$172,812MANUFACTURING - ONCE A VACCINE CANDIDATE HAS BEEN IDENTIFIED IN THE RESEARCH LAB, THE NEXT CHALLENGE IS TO APPLY THAT DISCOVERY TO THE CLINICAL SETTING. A NECESSARY PART OF THIS TRANSITION IS TO PRODUCE VACCINES UNDER CONTROLLED CONDITIONS SO THAT THEY ARE SUITABLE FOR USE IN HUMAN STUDIES. IDRI HAS DEVELOPED THE TYPE OF MANUFACTURING CAPABILITY REQUIRED TO MOVE A VACCINE FROM LATE STAGE RESEARCH TO EARLY CLINICAL STUDIES.
$3,054,074$2,704,649OTHER ACTIVITIES - IDRI'S CLINICAL GROUP DESIGNS AND CONDUCTS EARLY STAGE CLINICAL TRIALS TO TEST THE VACCINE CANDIDATES IDENTIFIED BY IDRI SCIENTISTS OR COLLABORATORS. THROUGH OUR NETWORK OF GLOBAL CONNECTIONS, THE CLINICAL TEAM IS ABLE TO LAUNCH CLINICAL TRIALS ALMOST ANYWHERE IN THE WORLD.$14,000
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$3,850,989TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$14,000TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$2,877,461TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$18,705,320TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document34IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee163EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountrySFForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members10GoverningBodyVotingMembersCnt
Independent Voting Member8IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonC STEPHEN CORDIALPersonNm
Phone2063810883PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11616 EASTLAKE AVE E SUITE 400AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98102ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (16 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
BRUCE CARTER PHD
CHAIRMAN5.00Yes (X)Yes (X)$0$0$0
DAVID PERRY
TREASURER5.00Yes (X)Yes (X)$0$0$0
ERIK IVERSON JD LLM
PRES., BUSINESS & OPS, SECRETARY40.00Yes (X)Yes (X)$284,942$0$25,904
GAIL CASSELL PHD
DIRECTOR5.00Yes (X)$0$0$0
MICHEL DEWILDE PHD
DIRECTOR5.00Yes (X)$0$0$0
CHRIS HENTSCHEL PHD
DIRECTOR5.00Yes (X)$0$0$0
FRANKLYN PRENDERGAST MD PHD
DIRECTOR5.00Yes (X)$0$0$0
MASSIMO RADAELLI PHD
DIRECTOR5.00Yes (X)$0$0$0
STEVEN REED PHD
PRESIDENT & CSO/DIRECTOR40.00Yes (X)Yes (X)$302,134$0$23,157
STEVE CORDIAL
DIRECTOR5.00Yes (X)$0$0$0
ROBERT LIN
VP, FINANCE40.00Yes (X)$126,159$0$6,905
ANNA MARIE BECKMANN PHD
VP, DEVELOPMENT & REGULATORY40.00$185,988$0$24,295Yes (X)
TANYA PARISH PHD
VP, DRUG DISCOVERY40.00$161,860$0$5,992Yes (X)
WINSTON WICOMB PHD LATG
DIRECTOR, VIVARIUM40.00$156,409$0$17,059Yes (X)
KIM CLARY
DIRECTOR, IP40.00$143,715$0$22,754Yes (X)
JOSHUA ODINGO PHD
DIRECTOR, CHEMISTRY40.00$142,045$0$21,234Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,503,252TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$147,300TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K20IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmCountryContractorAddress/ForeignAddress/CountryCdForeign PostalContractorAddress/ForeignAddress/ForeignPostalCd
XENOMETRICS LLC
2430 NEW HOLLAND PIKE SUITE 300LANCASTERPA17601RESEARCH$147,659
CEBU LEPROSY & TB RESEARCH FOUNDATION
RESEARCH$131,479PO BOX 727CEBURP6000-6053
CYPROTEX US LLC
313 PLEASANT STREETWATERTOWNMA02472RESEARCH$125,434
APPLIED STRATEGIES
951 MARINERS ISLAND BLVD SUITE 400SAN MATEOCA94404RESEARCH$125,000
DFNET RESEARCH INC
140 LAKESIDE AVENUE SUITE 310SEATTLEWA98122RESEARCH$110,426
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K6CntrctRcvdGreaterThan100KCnt
Government Grants$10,053,571GovernmentGrantsAmt
All Other Contributions$9,611,240AllOtherContributionsAmt
Total Contributions$19,664,811TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (4 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
LICENSING541700$2,851,050$2,851,050
SPONSORED RESEARCH541700$1,612,495$1,612,495
SERVICES AND CONTRACTS541700$1,205,219$1,205,219
VIVARIUM INCOME541700$429,875$429,875
FieldValueIRS element (for citing)
Total Program Service Revenue$6,098,639TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,521TotalRevenueColumnAmt
Exclusion$5,521ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,667,416TotalRevenueColumnAmt
Exclusion$1,667,416ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$2,645,047SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$1,793,405SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$851,642SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$851,642TotalRevenueColumnAmt
Exclusion$851,642ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescCURRENCY EXCHANGEDesc
Business561499BusinessCd
Total Revenue Column$11,373TotalRevenueColumnAmt
Exclusion$11,373ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$11,373OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$28,299,402TotalRevenueColumnAmt
Related Or Exempt Func Income$5,668,764RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$429,875UnrelatedBusinessRevenueAmt
Exclusion$2,535,952ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$14,000TotalAmt
Program Services$14,000ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$769,201TotalAmt
Program Services$298,833ProgramServicesAmt
Management And General$428,376ManagementAndGeneralAmt
Fundraising$41,992FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$7,991,191TotalAmt
Program Services$6,041,091ProgramServicesAmt
Management And General$1,832,353ManagementAndGeneralAmt
Fundraising$117,747FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$221,876TotalAmt
Program Services$167,642ProgramServicesAmt
Management And General$52,611ManagementAndGeneralAmt
Fundraising$1,623FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,228,721TotalAmt
Program Services$897,272ProgramServicesAmt
Management And General$319,606ManagementAndGeneralAmt
Fundraising$11,843FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$607,114TotalAmt
Program Services$437,729ProgramServicesAmt
Management And General$162,707ManagementAndGeneralAmt
Fundraising$6,678FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$405,655TotalAmt
Program Services$209,224ProgramServicesAmt
Management And General$196,431ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$71,597TotalAmt
Management And General$71,597ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$429,273TotalAmt
Program Services$270,372ProgramServicesAmt
Management And General$156,922ManagementAndGeneralAmt
Fundraising$1,979FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$1,834TotalAmt
Management And General$1,459ManagementAndGeneralAmt
Fundraising$375FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$148,692TotalAmt
Program Services$41,663ProgramServicesAmt
Management And General$107,622ManagementAndGeneralAmt
Fundraising-$593FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$163,402TotalAmt
Program Services$27,205ProgramServicesAmt
Management And General$136,197ManagementAndGeneralAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$1,196,118TotalAmt
Management And General$1,196,118ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$2,717,080TotalAmt
Program Services$2,104,519ProgramServicesAmt
Management And General$590,117ManagementAndGeneralAmt
Fundraising$22,444FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$330,073TotalAmt
Program Services$281,092ProgramServicesAmt
Management And General$48,967ManagementAndGeneralAmt
Fundraising$14FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$48,833TotalAmt
Program Services$15,340ProgramServicesAmt
Management And General$33,493ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$1,557,658TotalAmt
Program Services$1,353,083ProgramServicesAmt
Management And General$204,575ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$104,519TotalAmt
Program Services$15,470ProgramServicesAmt
Management And General$89,049ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
LAB SUPPLIES$3,472,109$3,310,160$161,949
SUBCONTRACTS$1,626,164$1,622,498$3,666
CONTRACTED SERVICES$1,152,376$1,114,891$37,485
REPAIRS & MAINTENANCE$427,135$276,242$150,893

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$421,219TotalAmt
Program Services$206,994ProgramServicesAmt
Management And General$212,836ManagementAndGeneralAmt
Fundraising$1,389FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$25,105,840TotalAmt
Program Services$18,705,320ProgramServicesAmt
Management And General$6,195,029ManagementAndGeneralAmt
Fundraising$205,491FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,338,775BOYAmt
EOY$4,140,713EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$5,198,288BOYAmt
EOY$4,571,109EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$12,720,073BOYAmt
EOY$11,327,238EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$642,237BOYAmt
EOY$1,582,284EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$56,514BOYAmt
EOY$183,091EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$24,187,905LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$8,995,035LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$15,015,611BOYAmt
EOY$15,192,870EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$1,145,047BOYAmt
EOY$95,159EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$45,433BOYAmt
EOY$112,636EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$1,643BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$36,163,621BOYAmt
EOY$37,205,100EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,726,256BOYAmt
EOY$2,767,026EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$464,869BOYAmt
EOY$1,715,092EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$17,658,281BOYAmt
EOY$16,837,485EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$19,849,406BOYAmt
EOY$21,319,603EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY-$857,454BOYAmt
EOY$1,213,376EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$17,171,669BOYAmt
EOY$14,672,121EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$16,314,215BOYAmt
EOY$15,885,497EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$36,163,621BOYAmt
EOY$37,205,100EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$3,193,562ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$1,031,492NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$2,590,788OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,410,786CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$20,127,852CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$11,743,860CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$9,413,720CurrentTaxYearMinus1YearAmt
Current Tax Year$19,664,811CurrentTaxYearAmt
Total$75,361,029TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,410,786CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$20,127,852CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$11,743,860CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$9,413,720CurrentTaxYearMinus1YearAmt
Current Tax Year$19,664,811CurrentTaxYearAmt
Total$75,361,029TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$23,087,758SubstantialContributorsTotAmt
Public Support Total170$52,273,271PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,157,313CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$896,761CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$683,996CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$727,807CurrentTaxYearMinus1YearAmt
Current Tax Year$1,672,937CurrentTaxYearAmt
Total$5,138,814TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$127,472CurrentTaxYearMinus4YearsAmt
Total$127,472TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$13,705CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus2 Years$500CurrentTaxYearMinus2YearsAmt
Current Tax Year$11,373CurrentTaxYearAmt
Total$25,578TotalAmt
FieldValueIRS element (for citing)
Total Support$80,652,893TotalSupportAmt
Gross Receipts Rltd Activities$14,630,546GrossReceiptsRltdActivitiesAmt
Public Support CY1700.64810PublicSupportCY170Pct
Public Support PY1700.62560PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:FormAndLineReferenceDesc
ExplanationMISCELLANEOUS - 2013 AMOUNT: $ 500. REIMBURSEMENTS - 2011 AMOUNT: $ 12,502. REFUNDS - 2011 AMOUNT: $ 1,203. CURRENCY EXCHANGE - 2015 AMOUNT: $ 11,373.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$15,203,205OtherCostOrOtherBasisAmt
Depreciation$2,787,254DepreciationAmt
Book Value$12,415,951BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$7,481,189OtherCostOrOtherBasisAmt
Depreciation$6,207,781DepreciationAmt
Book Value$1,273,408BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,503,511OtherCostOrOtherBasisAmt
Book Value$1,503,511BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$15,192,870TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDEFERRED RENTDesc
Amt$16,837,485Amt
FieldValueIRS element (for citing)
Total Liability$16,837,485TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$23,346,504TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$1,031,492NetUnrealizedGainsInvstAmt
Other Revenue-$3,921,406OtherRevenueAmt
Revenue Not Reported-$4,952,898RevenueNotReportedAmt
Revenue Subtotal$28,299,402RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$28,299,402TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$24,185,782TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$276,060OtherExpensesIncludedAmt
Expenses Not Reported$276,060ExpensesNotReportedAmt
Expenses Subtotal$23,909,722ExpensesSubtotalAmt
Other Expenses Not Included$1,196,118OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$1,196,118ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$25,105,840TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:ROYALTY EXPENSES INCLUDED IN INCOME ON FINANCIAL STATEMENTS PRIOR YEAR PLEDGE ADJUSTMENT INCLUDED IN INCOME ON FINANCIAL STATEMENTS RELATED ORGANIZATION REVENUES INCLUDED IN AUDITED FINANCIAL STATEMENTS FINANCIAL STATEMENT ELIMINATIONS
PART XII, LINE 2D - OTHER ADJUSTMENTS:RELATED ORGANIZATION EXPENSES INCLUDED IN AUDITED FINANCIAL STATEMENTS FINANCIAL STATEMENT ELIMINATIONS
PART XII, LINE 4B - OTHER ADJUSTMENTS:ROYALTY EXPENSES INCLUDED IN INCOME ON FINANCAL STATEMENTS

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
SOUTH ASIA00PROGRAM SERVICESRESEARCH$518,454
EUROPE (INCLUDING ICELAND & GREENLAND)00PROGRAM SERVICESRESEARCH$221,029
SUB-SAHARAN AFRICA00PROGRAM SERVICESRESEARCH$220,161
EAST ASIA AND THE PACIFIC00PROGRAM SERVICESRESEARCH$135,105
NORTH AMERICA00PROGRAM SERVICESRESEARCH$12,926
MIDDLE EAST AND NORTH AFRICA00PROGRAM SERVICESRESEARCH$865
SUB-SAHARAN AFRICA00PROGRAM RELATED INVESTMENTPROGRAM RELATED INVESTMENT$112,636
SUB-SAHARAN AFRICAPROGRAM SERVICESRESEARCH
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee0ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$1,221,176SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,221,176TotalSpentAmt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp OwnershipYes (1)ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3:FormAndLineReferenceDesc
ExplanationTHE EXPENDITURES REPORTED ON SCHEDULE F, PART I, LINE 3 ARE ON ACCRUAL BASIS OF ACCOUNTING.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable

Recipient Business Name RecipientBusinessName

FieldValueIRS element (for citing)
Business Name Line1WHITMAN COLLEGEBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1345 BOYER AVENUEAddressLine1Txt
CityWALLA WALLACityNm
State AbbreviationWAStateAbbreviationCd
ZIP99362ZIPCd
FieldValueIRS element (for citing)
Recipient EIN910567740RecipientEIN
IRC Section501(C)(3)IRCSectionDesc
Cash Grant$9,000CashGrantAmt
Valuation Method UsedN/AValuationMethodUsedDesc
Non Cash AssistanceN/ANonCashAssistanceDesc
Purpose Of GrantGENERAL SUPPORTPurposeOfGrantTxt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationALL PAYMENTS MADE FOR PROGRAM SERVICES WITHIN THE U.S. ARE BASED ON LEGAL AGREEMENTS BETWEEN IDRI AND THE PARTY RECEIVING PAYMENT. THESE AGREEMENTS INCLUDE REQUIREMENTS FOR BOTH PROGRESS AND FINANCIAL REPORTING BASED ON TIME PERIODS OR MILESTONE ACHIEVEMENTS. REPORTS ARE REVIEWED BY SCIENTIFIC AND ADMINISTRATIVE STAFF TO ENSURE THAT THE GOALS OF THE AGREEMENT AND ANY SPECIFIC FINANCIAL RESTRICTIONS ARE BEING MET BEFORE FURTHER PAYMENT IS MADE. MOST AGREEMENTS ALSO CONTAIN A CLAUSE GIVING IDRI THE RIGHT TO AUDIT FINANCIAL RECORDS OF THE PARTY IF NEEDED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ERIK IVERSON JD LLM
PRES., BUSINESS & OPS, SECRETARY$284,942$0$0$0$0$0$7,950$0$17,954$0$310,846$0$0$0
STEVEN REED PHD
PRESIDENT & CSO/DIRECTOR$302,134$0$0$0$0$0$7,950$0$15,207$0$325,291$0$0$0
ANNA MARIE BECKMANN PHD
VP, DEVELOPMENT & REGULATORY$185,988$0$0$0$0$0$6,933$0$17,362$0$210,283$0$0$0
TANYA PARISH PHD
VP, DRUG DISCOVERY$161,860$0$0$0$0$0$5,992$0$0$0$167,852$0$0$0
WINSTON WICOMB PHD LATG
DIRECTOR, VIVARIUM$156,409$0$0$0$0$0$5,851$0$11,208$0$173,468$0$0$0
KIM CLARY
DIRECTOR, IP$143,715$0$0$0$0$0$5,392$0$17,362$0$166,469$0$0$0
JOSHUA ODINGO PHD
DIRECTOR, CHEMISTRY$142,045$0$0$0$0$0$3,872$0$17,362$0$163,279$0$0$0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART 1, LINE 6:THERE WERE EIGHT VOLUNTEER BOARD MEMBERS DURING THE YEAR. BOARD MEMBERS PARTICIPATE IN STRATEGIC PLANNING, EXECUTIVE LEADERSHIP RECRUITMENT AND SELECTION, INTELLECTUAL PROPERTY STRATEGY, AND IDENTIFICATION OF INSTITUTIONAL LIABILITY. THEY COME FROM A VARIETY OF BACKGROUNDS AND DEMONSTRATE FINANCIAL EXPERTISE, REAL ESTATE LEASING/PURCHASING EXPERTISE, BIO-MEDICAL NOT-FOR-PROFIT EXPERTISE, AND AN UNDERSTANDING OF BUSINESS AND BIOTECH LICENSING.
FORM 990, PART VI, SECTION A, LINE 1STEVEN REED, PRESIDENT & CSO, AND ERIK IVERSON, PRESIDENT OF BUSINESS & OPERATIONS, ARE VOTING BOARD MEMBERS. THEY ARE ALSO COMPENSATED BY THE ORGANIZATION FOR THEIR POSITIONS AS PRESIDENT & CSO AND PRESIDENT OF BUSINESS & OPERATIONS, RESPECTIVELY. THEREFORE, THEY ARE NOT INDEPENDENT VOTING BOARD MEMBERS.
FORM 990, PART VI, SECTION B, LINE 11A DRAFT COPY OF THE FORM 990 AND FORM 990-T IS PRESENTED TO THE AUDIT COMMITTEE FOR REVIEW. THE AUDIT COMMITTEE REVIEWS AND APPROVES THE FORM 990 AND 990-T ON BEHALF OF THE IDRI BOARD OF DIRECTORS. ALL BOARD MEMBERS RECEIVE A COPY OF THE FORM 990 AND 990-T PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CEACH JANUARY, MEMBERS OF THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT ARE GIVEN A COPY OF THE CONFLICT OF INTEREST POLICY. THEY ARE REQUIRED TO FILL IT OUT AND RETURN IT BY THE FIRST BOARD MEETING - USUALLY SOMETIME IN THE FIRST QUARTER. THE SENIOR VICE PRESIDENT OF OPERATIONS AND GENERAL COUNSEL REVIEWS THE QUESTIONNAIRES AND SUMMARIZES THE RESULTS. THE RESULTS ARE COMMUNICATED TO THE BOARD OF DIRECTORS. TO THE EXTENT THAT THERE ARE ANY CONFLICTS, THE MEMBER IS RECUSED FROM ANY DECISION MAKING THAT WOULD INCLUDE THE CONFLICT. WHEN THE OCCASION ARISES, THOSE MEMBERS ALSO REMIND THE GROUP (MANAGEMENT TEAM OR BOARD) THAT THERE IS A POTENTIAL CONFLICT WHEN SPECIFIC DISCUSSION TOPICS ARISE.
FORM 990, PART VI, SECTION B, LINE 15THE COMPENSATION COMMITTEE CONDUCTED A FULL CEO PERFORMANCE AND COMPENSATION REVIEW, INITIATED IN MAY 2014, USING AN OUTSIDE INDEPENDENT CONSULTANT. THE REPORT IS IN THE BOARD MATERIALS AND IN THE PERSONNEL FILE. THE DECISIONS ARE IN THE COMPENSATION COMMITTEE NOTES. COMPARATIVE COMPENSATION INFORMATION WAS USED FROM THE CULPEPPER AND RADFORD PROFESSIONAL COMPENSATION FIRMS. THE BOARD CHAIR ALSO DOES AN ANNUAL REVIEW OF ALL OTHER OFFICERS AND KEY EMPLOYEES AND WORKS WITH THE HUMAN RESOURCES DEPARTMENT TO DETERMINE IF THE COMPENSATION IS ADEQUATE. IF AN ADJUSTMENT IS DEEMED NECESSARY, THE BOARD CHAIR CONVENES THE COMPENSATION COMMITTEE AND THE ADJUSTMENT IS ADDRESSED. THE BOARD CHAIR REPORTS BACK TO THE HUMAN RESOURCES DEPARTMENT WHO FOLLOWS THROUGH WITH THE COMMITTEE'S RECOMMENDATION.
FORM 990, PART VI, SECTION C, LINE 19THE IDRI AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON OUR WEBSITE, WWW.IDRI.ORG. REQUESTS FOR OTHER INFORMATION SUCH AS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE HANDLED THROUGH OUR FINANCE DEPARTMENT AND INFORMATION IS DISTRIBUTED AS REQUESTED UNLESS CONFIDENTIAL IN NATURE.
FORM 990, PART XI, LINE 9:PLEDGE ADJUSTMENT -2,590,788.

Schedule R IRS990ScheduleR

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1AFRIGEN BIOLOGICS (PTY) LTDBusinessNameLine1Txt

Foreign Address ForeignAddress

FieldValueIRS element (for citing)
Address Line137 STRAND STREETAddressLine1Txt
CityCAPE TOWNCityNm
Province Or StateWESTERN CAPEProvinceOrStateNm
CountrySFCountryCd
Foreign Postal8001ForeignPostalCd
FieldValueIRS element (for citing)
Primary ActivitiesRESEARCHPrimaryActivitiesTxt
Legal Domicile Foreign CountrySFLegalDomicileForeignCountryCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1INFECTIOUS DISEASE RESEARCH INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Entity TypeCEntityTypeTxt
Share Of Total Income-$221,207ShareOfTotalIncomeAmt
Share Of EOY Assets$141,731ShareOfEOYAssetsAmt
Ownership0.51000OwnershipPct
Controlled OrganizationYes (1)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgYes (1)LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (1)ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (3 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
AFRIGEN BIOLOGICS (PTY) LTD
O$115,551COST
AFRIGEN BIOLOGICS (PTY) LTD
Q$5,475COST
AFRIGEN BIOLOGICS (PTY) LTD
D$136,546PER AGREEMENT